Integrated Microfluidic Chip for Multi-Biomarker Diagnostics

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current microfluidic systems are limited in their ability to simultaneously analyze genetic, protein, and cellular markers from a single sample, requiring multiple samples and specialized facilities, which is impractical for point-of-care diagnostics and leads to inconsistent results due to complex inter-relatedness of biomarkers and poor portability.

Innovation Solution

A portable microfluidic platform with a single integrated chip that includes a sample input, separator, reaction channels, thermoelectric semiconductor, LED array, and control unit for simultaneous analysis of genetic, protein, and cellular markers from a small sample volume, enabling on-chip separation, PCR, protein arrays, and cell detection.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If multiple separate diagnostic chips are used for different biomarkers, then each analysis can be performed with dedicated reagents and controls, but the system becomes complex, requires multiple samples, and increases time consumption

Engineering Contradiction:
Improvediagnostic accuracyVSAvoidsystem complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent merges multiple diagnostic functions (gene expression analysis, protein detection, cell analysis) into a single integrated microfluidic chip. The chip includes multiple reaction channels that can simultaneously process different biomarkers from one sample, eliminating the need for separate diagnostic chips and reducing system complexity while maintaining diagnostic accuracy through dedicated reagent compartments and detection pathways for each biomarker type.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The microfluidic chip is designed as a universal platform capable of performing multiple analysis types (PCR for genes, antibody-based assays for proteins, and cell morphology analysis) simultaneously. The chip includes universal features such as a common sample input, integrated separator, and shared detection system that can accommodate different biomarkers, making it a multi-functional diagnostic device that replaces multiple specialized systems.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Measurement precision

If multiple samples are taken from patients for different analyses, then each biomarker can be detected with appropriate reagents, but patient comfort decreases and time consumption increases

Engineering Contradiction:
Improvebiomarker detection capabilityVSAvoidtime consumption
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent combines multiple biomarker detection capabilities into a single analytical run using one patient sample. The integrated chip processes genetic, protein, and cellular biomarkers simultaneously from one input sample, reducing the number of required samples from multiple to one, thereby decreasing time consumption and improving patient comfort while maintaining comprehensive diagnostic coverage.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The chip performs preliminary sample separation and preparation in advance through an integrated separator that divides the sample into appropriate streams for different analysis types before the actual detection begins. This preliminary action organizes the single sample into multiple reaction channels ready for simultaneous processing, eliminating the need for multiple separate sample collection and preparation steps.

Inventive Principle:
Principle #10Preliminary action

3Reliability

If conventional PCR machines and lab facilities are used, then established protocols can be followed, but the system is expensive, requires sterile labs, and needs skilled technicians

Engineering Contradiction:
Improvetest reliabilityVSAvoidfacility requirements
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent merges multiple laboratory functions (sample separation, PCR amplification, protein detection, cell analysis, and data processing) into a single portable microfluidic system. This integration eliminates the need for separate sterile lab facilities and specialized equipment for each analysis type, reducing facility requirements while maintaining test reliability through controlled reaction conditions and automated protocols within the integrated chip.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The microfluidic chip is designed to perform self-contained analysis with minimal external intervention. The integrated system automatically controls reagent delivery, temperature cycling for PCR, detection parameter acquisition, and preliminary data processing, reducing the need for skilled technicians and sterile laboratory environments while maintaining reliable diagnostic results through automated quality control features.

Inventive Principle:
Principle #25Self-service

4Ease of operation

If microfluidic systems are made portable with compact design, then ease of use in clinical settings improves, but device complexity may increase due to integration requirements

Engineering Contradiction:
ImproveportabilityVSAvoidintegration complexity
Core Design Contradiction:
Ease of operationVSDevice complexity

Solution Approach 1:

The patent segments the diagnostic system into a modular architecture where the microfluidic chip serves as a portable analysis unit that can be coupled with a separate, simplified control and detection device. This segmentation allows the chip to maintain its integrated multi-functional capabilities while the external controller handles complex operations, achieving portability without excessive overall system complexity.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent extracts the complex integration requirements from the portable chip itself by implementing passive microfluidic features such as pressure-driven flow control and on-chip reagent reservoirs that eliminate the need for active pumps and complex temperature control systems. This extraction of complexity into simplified passive components enables portability while maintaining the integrated analysis capabilities.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This solution allows for rapid, accurate, and efficient diagnosis of diseases from a small sample volume, improving diagnostic accuracy and suitability for clinical settings by integrating mechanical, thermal, optical, and electronic control modules within a compact, portable device.

Implementation Method 1

a separator connected to the sample input by a separation channel; one or more reaction channels, each reaction channel being connected to the separator

Methodology Applied
Scientific EffectDensity separation: Density Gradient

Implementation Method 2

a thermoelectric semiconductor arranged to heat or cool one or more of said channels

Methodology Applied
Scientific EffectThermoelectric effect: Peltier Effect

Implementation Method 3

an LED array arranged to emit radiation over specific wavelengths to the microfluidic chip

Methodology Applied
Scientific EffectLight emission: Light Emitting Diode

Implementation Method 4

a detector arranged to detect fluorescence from said microfluidic chip

Methodology Applied
Scientific EffectFluorescence detection: Fluorescence

Data Source

PatentUS10906043B2Microfluidic based integrated sample analysis system
Publication Date: 2021.02.02 GETWELL HEALTH TECH SHENZEN CO LTD
  • US10906043B2 patent drawing
  • US10906043B2 patent drawing
  • US10906043B2 patent drawing

AI summary

A portable microfluidic system capable of rapid diagnosis is described, which is able to analyze genetic, protein and cell composition of a sample in parallel for specific diseases from a relatively small sample. The method uses a single microfluidic chip integrated into a unique portable microfluidic platform and provides improved diagnostic accuracy, allows for frequent monitoring and is suitable for easy use in clinical settings.